Fujii N - Search Results

1

A single retroviral gag precursor signal peptide recognized by FBL-3 tumor-specific cytotoxic T lymphocytes.

Kondo T, Uenishi H, Shimizu T, Hirama T, Iwashiro M, Kuribayashi K, Tamamura H, Fujii N, Fujisawa R, Miyazawa M, et al. Kondo T, et al. Among authors: fujii n. J Virol. 1995 Nov;69(11):6735-41. doi: 10.1128/JVI.69.11.6735-6741.1995. J Virol. 1995. PMID: 7474084 Free PMC article.

2

Fine structure of a virus-encoded helper T-cell epitope expressed on FBL-3 tumor cells.

Shimizu T, Uenishi H, Teramura Y, Iwashiro M, Kuribayashi K, Tamamura H, Fujii N, Yamagishi H. Shimizu T, et al. Among authors: fujii n. J Virol. 1994 Dec;68(12):7704-8. doi: 10.1128/JVI.68.12.7704-7708.1994. J Virol. 1994. PMID: 7525983 Free PMC article.

3

Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells.

Iwashiro M, Kondo T, Shimizu T, Yamagishi H, Takahashi K, Matsubayashi Y, Masuda T, Otaka A, Fujii N, Ishimoto A, et al. Iwashiro M, et al. Among authors: fujii n. J Virol. 1993 Aug;67(8):4533-42. doi: 10.1128/JVI.67.8.4533-4542.1993. J Virol. 1993. PMID: 7687300 Free PMC article.

4

Overlapping epitopes of friend murine leukemia virus gag-encoded leader sequence recognized by single cytotoxic T-lymphocyte clones.

Uenishi H, Iwanami N, Kuribayashi K, Tamamura H, Fujii N, Nakatani T, Kawasaki T, Yamagishi H. Uenishi H, et al. Among authors: fujii n. Immunol Lett. 1998 May;62(1):33-8. doi: 10.1016/s0165-2478(98)00020-0. Immunol Lett. 1998. PMID: 9672145

5

Induction of cross-reactivity in an endogenous viral peptide non-reactive to FBL-3 tumor-specific helper T-cell clones.

Uenishi H, Iwanami N, Yamagishi H, Nakatani T, Kawasaki T, Tamamura H, Fujii N, Kuribayashi K. Uenishi H, et al. Among authors: fujii n. Microbiol Immunol. 1998;42(7):479-84. doi: 10.1111/j.1348-0421.1998.tb02313.x. Microbiol Immunol. 1998. PMID: 9719100 Free article.

6

Mutations conferring resistance to human immunodeficiency virus type 1 fusion inhibitors are restricted by gp41 and Rev-responsive element functions.

Nameki D, Kodama E, Ikeuchi M, Mabuchi N, Otaka A, Tamamura H, Ohno M, Fujii N, Matsuoka M. Nameki D, et al. Among authors: fujii n. J Virol. 2005 Jan;79(2):764-70. doi: 10.1128/JVI.79.2.764-770.2005. J Virol. 2005. PMID: 15613304 Free PMC article.

7

Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection.

Murakami T, Zhang TY, Koyanagi Y, Tanaka Y, Kim J, Suzuki Y, Minoguchi S, Tamamura H, Waki M, Matsumoto A, Fujii N, Shida H, Hoxie JA, Peiper SC, Yamamoto N. Murakami T, et al. Among authors: fujii n. J Virol. 1999 Sep;73(9):7489-96. doi: 10.1128/JVI.73.9.7489-7496.1999. J Virol. 1999. PMID: 10438838 Free PMC article.

8

Peptide-lead CXCR4 antagonists with high anti-HIV activity.

Fujii N, Tamamura H. Fujii N, et al. Curr Opin Investig Drugs. 2001 Sep;2(9):1198-202. Curr Opin Investig Drugs. 2001. PMID: 11717804 Review.

9

Two orthogonal approaches to overcome multi-drug resistant HIV-1s: development of protease inhibitors and entry inhibitors based on CXCR4 antagonists.

Tamamura H, Fujii N. Tamamura H, et al. Among authors: fujii n. Curr Drug Targets Infect Disord. 2004 Jun;4(2):103-10. doi: 10.2174/1568005043340957. Curr Drug Targets Infect Disord. 2004. PMID: 15180458 Review.

10

The therapeutic potential of CXCR4 antagonists in the treatment of HIV.

Fujii N, Nakashima H, Tamamura H. Fujii N, et al. Expert Opin Investig Drugs. 2003 Feb;12(2):185-95. doi: 10.1517/13543784.12.2.185. Expert Opin Investig Drugs. 2003. PMID: 12556213 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,111 results

Search Page

Filters